Open Outcrier Sign Up/Sign In
Sign Up/Sign In

Open Outcrier is a news and chat platform geared toward options traders.


What's Inside

Open Outcrier Feed

Tons of trades and insights that are not posted to other socials.

The Pit

Real-time chat with other traders and the Open Outcrier folks themselves.

Full Search

Search through news articles, posts, and chat.

Custom Benzinga Feed

More in-depth than the free one on their site.

Daily Digest

Pre-market news sent straight to your inbox.

Sign Up Today

Free 2-week trial, no credit card required

Free Email Digest

$0/mo

  • Daily digest, delivered via email

Pro Platform Access

$99/mo

2 week free trial, no credit card required. One month free when you subscribe yearly.
  • Full access to the platform
  • Open Outcrier Feed
  • Real-time Chat
  • Custom Benzinga News Feed
  • Daily Email Digest
Try for Free

Compare Plans

Free Email Digest Pro Platform Access
Daily Email Digest Optional
Access to Open Outcrier Platform
Open Outcrier Feed
Real-time Chat with Other Traders
Custom Benzinga News Feed
Platform-spanning Cashtag Search
Try for Free

What We're Watching Today

Econ Calendar Mon 4/20/253-Month Bill Auction 11:30 AM ET 6-Month Bill Auction 11:30 AM ET
Oil jumps, stocks pull back as Mideast ceasefire hangs in the balance - Reuters
Iran Wavers on Peace Talks as Tensions Rise After US Seizes Ship - BBG
‘Resumption of hostilities’: seized ship, vessel attacks push U.S.-Iran ceasefire toward brink - CNBC
Hormuz Traffic at Standstill After US Navy Seizes Iranian Ship - BBG
Trump Says Iran Talks Are On, Sparking Push to Bridge Gaping Divides - WSJ
Iran's president stresses importance of diplomacy while noting distrust of U.S. - Reuters
Israel entrenches hold on south Lebanon, warns residents to stay out - Reuters
U.A.E. Asks U.S. About a Wartime Financial Lifeline - WSJ
Carney says Canada's US ties have become a weakness - Reuters
Hegseth’s Feud With Army Secretary Spills Into Public View - WSJ
FBI Director Kash Patel vows to sue The Atlantic over alcohol abuse claims - CNBC
Warsh’s Fed Confirmation Hearing Is Next Driver for US Debt - BBG
Fed nominee Warsh prepares for monetary policy road test before Senate panel - Reuters
Kevin Warsh Pitched a Case for Fed Rate Cuts. His Future Colleagues Are Skeptical. - WSJ
Fed chair nominee Warsh has big ideas. Here are some, in his own words - Reuters
Kevin Warsh would be the first tech bro Fed chair. How Silicon Valley shaped him - CNBC
Ukraine strikes Russian oil refineries hours after US waives sanctions on Moscow’s oil - CNN
Starmer Faces Showdown With Fired Official on Mandelson Saga - BBG
Germany Is Reinventing Itself as a Weapons Factory - WSJ
China voices concern over US seizure of Iranian cargo ship, urges further talks - Reuters
China warns against joint US, Philippines and Japan drills eroding regional trust - Reuters
China curtailing, not banning fuel exports, shipping data shows
Japan households' inflation expectations steady, BOJ April hike bets fade
Bond investors propose crisis 'pause clauses' for emerging countries - Reuters
Oil prices jump after Iran and U.S. attack commercial ships as tensions escalate over Strait of Hormuz - CNBC
Big Oil Plows Billions Into Far-Flung Drilling Sites to Escape Iran Turmoil - WSJ
Dollar pushes to one-week high as US-Iran tensions reignite - Reuters
Gold falls on stronger dollar amid renewed U.S.-Iran tensions - CNBC
Iran willing to attend second round of talks with US, Pakistan officials - AP
$BLD (+18.9% pre) $QXO to Acquire TopBuild for $17 Billion (TopBuild stockholders will have the right to elect to receive $505 in cash or 20.2 shares of QXO common stock)
$ASTS (-12.0% pre) AST Drops as Blue Origin Rocket Places Satellite in Wrong Orbit - BBG
$MRVL (+5.5% pre) Marvell shares gain on report of deal talks with $GOOGL Google to develop two AI chips (1/2)
$MRVL (+5.5% pre) JPMorgan stated that reports suggesting $MRVL won the $GOOGL Google TPU business are inaccurate, noting that Google is in discussions with multiple parties and $AVGO remains the primary supplier. (2/2)
$NVDA (-0.9% pre) $GOOGL Google Eyes New Chips to Speed Up AI Results, Challenging Nvidia - BBG
$META (-0.9% pre) Exclusive: Meta targets May 20 for first wave of layoffs; additional cuts later in 2026 - Reuters
Regulators monitor Anthropic's Mythos for banking risks - Reuters
$HON (-0.3% pre) HONEYWELL TO SELL PRODUCTIVITY SOLUTIONS AND SERVICES BUSINESS TO $BRC BRADY CORPORATION
$AAL (-3.1% pre) American Airlines falls 3% premarket after dismissing $UAL United megamerger - CNBC
$SOC (+3.3% pre) Sable Offshore provides operational and financial updates
$USAR (+8.8% pre) USA Rare Earth to buy Brazil's Serra Verde in ~$2.8B cash and stock deal
$UNH (-0.5% pre) UnitedHealth Isn’t Out of the Woods With $6 Billion Medicare Hit - BBG
$RILY (-2.6% pre) BRC Group plans to buy back minority shares, merge units
$JPM $C JPMorgan and Citi Square Off on the Next Payments Frontier - BBG
Crypto Hack Sparks $9 Billion Outflows From Biggest DeFi Lender - BBG
$TURB (+16.7% pre) Turbo Energy partners with Hithium for AI-driven battery systems in Europe
$FRMI (-21.8% pre) Fermi Shares Plunge After Announcing Departure of CEO
$KSPI (+1.9% pre) China’s Tencent Invests in Kazakhstan Fintech Company Kaspi.kz
$ADTX (-2.3% pre) Standard HER2 test fell short as Dana-Farber assessed Enhertu outcomes
$AKTX (-4.8% pre) Bladder, lung and breast models show Akari drug beats TROP2 rivals
$ARTL (+32.9% pre) Artelo says non-opioid pain drug had no serious drug-related events
$CATX (+7.1% pre) Perspective Therapeutics reports interim trial results for NET therapy
$ATAI $CMPS $DFTX $GHRS $HELP Psychedelic stocks rally after Trump orders faster PTSD research; Compass Pathways, Atai lead gains
$GLSI (+3.1% pre) The company unveiled new Phase 3 data suggesting its breast cancer vaccine candidate could work across a broader patient population than initially targeted
$NKTR (+17.2% pre) Nektar Therapeutics reports positive 52-week data for alopecia areata drug trial
$OCS (+1.6% pre) 800+ patients finish Oculis diabetic eye-drop trials before June data
$PASG (-23.3% pre) Passage Bio's shares hit on FDA requirement over pivotal trial for dementia gene therapy
$PBM (+72.4% pre) Ibogaine research faces supply shortages; Psyence says doses are ready
$PRLD (+12.8% pre) Prelude Therapeutics Highlights Promising PRT13722 Preclinical Results (1/2)
$PRLD (+12.8% pre) Prelude Therapeutics prices $90M stock offering at $4.44/share (2/2)
$TOVX (+73.1% pre) Theriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting
$ZLAB (+2.4% pre) Zai Lab (ZLAB), Amgen $AMGN Partner to Evaluate Combination Lung Cancer Therapy; Zai Lab stock rises on positive trial data for cancer drug
$BOH (-2.6% pre) Bank of Hawaii (NYSE:BOH) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings
$CLF (-3.0% pre) Cleveland-Cliffs: Q1 Earnings Snapshot
$NNOX (-12.3% pre) Nanox Announces Fourth Quarter of 2025 Financial Results and Provides Business Updates
Top Earnings Mon 4/20 Aft: $AGNC $ALK $BOKF $FLXS $HBCP $NTST $RBB $SFBS $STLD $WASH $WTFC $ZION
$ADBE (+2.2% pre) Adobe Unveils Agents for Businesses Amid Threat of AI Disruption
$LLY (-0.3% pre) Lilly to acquire Kelonia Therapeutics for up to $7 billion
$AGIO (-14.7% pre) $NVO Novo Nordisk’s new pill cuts sickle cell pain crises, boosting outcomes and sending Agios Pharma shares down after strong trial results
Upgrades 4/20: $ACLS $AEP $APD $ARCO $BIIB $CLDX $ECL $LAKE $MLCO $OKTA $OSCR $PLXS $TRP $UBS $ULTA $WBI $WMB
Downgrades 4/20: $ATEN $BBVA $BEAT $CAR $CNTA $DB $DOCS $EIX $ES $ETR $EXC $GMTL $GTLB $HESM $INTC $JANX $LION $MHK $NWG $NXPI $ORKT $QRVO $SNDR $SNY $SO $SWKS $TVRD $VALE $VNRX $WLK
+Initiations 4/20: $BUDA $CADL $CCJ $FRST $HIT $IONQ $MP $OPHC $QUBT $SERV $USAR $VLY $VOYA $XNDU
$WLDS (+58.9% pre) Wearable Devices targets AR glasses control, with AWE 2026 demo planned
$CVM (-16.2% pre) Form S-1 CEL SCI CORP
$SBC (-24.3% pre) SBC Medical prices secondary offering of 3.1 million shares at $3.25
Top Shareholder Meetings: $AVGO $DK $HCC $IRD $TZOO
Top Analyst/Investor Calls: $CNS $WFC
Top Conferences: o American Association for Cancer Research Meeting o Adobe Summit o American Academy of Neurology Meetingv